一个可诱导西梅普雷维尔的分子开关,用于控制细胞和基因疗法
Stacey E Chin1, Christina Schindler1, Lisa Vinall1
1Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Nature communications
|November 27, 2023
概括
研究人员开发了一种新的化学诱导二元化 (CID) 系统,使用已批准的药物来控制生物过程. 这种新的CID系统有效地触发了瘤细胞的亡,导致小鼠的瘤完全回归.
科学领域:
- 合成生物学 合成生物学
- 分子开关 分子开关
- 药物开发 药物开发
背景情况:
- 化学诱导二元化 (CID) 模块是控制生物过程的宝贵分子开关.
- 目前的CID系统主要用于体外应用.
- 临床翻译需要具有安全诱导剂和非免疫原蛋白成分的CID模块.
研究的目的:
- 为潜在的临床应用确定和描述一种新的CID模块.
- 评估一种新的CID系统对控制基因表达和亡的安全性和有效性.
- 在癌症模型中评估CID系统的体内治疗潜力.
主要方法:
- 开发了一个CID模块,利用西梅普雷维尔和C型肝炎病毒NS3/4A蛋白酶.
- 在实验室中证明了基因表达和亡的控制.
- 在异种移植小鼠模型中测试了CID系统在瘤细胞中诱导亡的能力.
主要成果:
- 基于西梅普雷维尔的CID模块在体外有效控制生物过程.
- 使用CID系统实现了瘤细胞中亡的快速诱导.
- 在CID系统治疗后的异种移植小鼠模型中观察到完整的瘤回归.
结论:
- 一个新的,口服可用的CID模块成功开发和验证.
- 这种CID系统在临床环境中对控制细胞和基因疗法充满希望.
- 开发的CID模块为癌症治疗提供了一个新的工具,有可能完全消除瘤.
更多相关视频
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
9.3K
10:42A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
Published on: December 12, 2017
15.3K
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Eukaryotic Transcription Inhibitors
9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
